|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.42 USD | -1.11% |
|
-4.76% | -31.18% |
| 05-29 | Canaccord Genuity Initiates Claritev at Buy With $32 Price Target | MT |
| 05-18 | Sector Update: Healthcare Stocks Advance Late Afternoon | MT |
Company Valuation: Claritev Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,828 | 735 | 935.3 | 239 | 706.5 | 501.5 | - | - |
| Change | - | -74.01% | 27.25% | -74.44% | 195.58% | -29.01% | - | - |
| Enterprise Value (EV) 1 | 2,828 | 735 | 935.3 | 239 | 706.5 | 5,050 | 5,030 | 4,955 |
| Change | - | -74.01% | 27.25% | -74.44% | 195.58% | 614.76% | -0.4% | -1.49% |
| P/E | 27.7x | -1.28x | -10.3x | -0.15x | -2.47x | -1.85x | -2.05x | -2.14x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0x | 0.1x | -0x | 0x | 0.23x | 0.21x | 0.47x |
| Capitalization / Revenue | 2.53x | 0.68x | 0.97x | 0.26x | 0.73x | 0.5x | 0.48x | 0.46x |
| EV / Revenue | 2.53x | 0.68x | 0.97x | 0.26x | 0.73x | 5.08x | 4.84x | 4.58x |
| EV / EBITDA | 3.37x | 0.96x | 1.51x | 0.41x | 1.17x | 8.31x | 7.97x | 7.49x |
| EV / EBIT | 7.32x | 2.45x | 5.77x | -0.17x | 24.6x | 96x | 53.2x | 41.1x |
| EV / FCF | - | - | - | - | - | 631x | - | 69.8x |
| FCF Yield | - | - | - | - | - | 0.16% | - | 1.43% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 6.4 | -36 | -5.6 | -101.9 | -17.3 | -15.93 | -14.38 | -13.73 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,118 | 1,080 | 961.5 | 930.6 | 965.4 | 993.4 | 1,038 | 1,082 |
| EBITDA 1 | 838.3 | 768.7 | 618 | 576.7 | 602.6 | 607.7 | 630.8 | 661.8 |
| EBIT 1 | 386.1 | 299.5 | 162 | -1,390 | 28.76 | 52.57 | 94.48 | 120.7 |
| Net income 1 | - | - | - | -1,646 | -284.3 | -269.6 | -241.5 | -228.8 |
| Net Debt 1 | - | - | - | - | - | 4,548 | 4,528 | 4,453 |
| Reference price 2 | 177.20 | 46.00 | 57.60 | 14.78 | 42.75 | 29.42 | 29.42 | 29.42 |
| Nbr of stocks (in thousands) | 15,957 | 15,978 | 16,237 | 16,171 | 16,526 | 17,048 | - | - |
| Announcement Date | 2/17/22 | 2/28/23 | 2/29/24 | 2/25/25 | 2/23/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.85x | 5.08x | 8.31x | -.--% | 502M | |
| -176.61x | 25.86x | 62.11x | -.--% | 73.41B | |
| 38.97x | 2.98x | 23.62x | 1.13% | 4.35B | |
| 106.01x | 13.64x | 19.62x | 0.28% | 3.44B | |
| -26.18x | - | - | 0.1% | 1.29B | |
| 42.51x | 17.55x | 27.23x | 0.54% | 1.24B | |
| 15.55x | - | - | 0.37% | 1.17B | |
| 24.06x | 3.78x | 13.58x | 0.68% | 1.1B | |
| Average | 2.81x | 11.48x | 25.75x | 0.39% | 10.81B | |
| Weighted average by Cap. | -142.99x | 23.64x | 56.91x | 0.09% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CTEV Stock
- Valuation Claritev Corporation
Select your edition
All financial news and data tailored to specific country editions
